District Court, E.D. New York October 30, 2002, CV 02-2018(JBW) (Wax v. Aventis Pasteur, Inc.)

AMENDED MEMORANDUM ORDER

WEINSTEIN, Senior District Judge.

The central question is whether thimero-sal is “a part of’ a children’s “vaccine” for purposes of the National Vaccine Injury Compensation Program (Program).

See

42 U.S.C. § 300aa — 10 et seq. (2000). Plaintiffs allegedly suffer from autism caused by thimerosal. Defendants have moved to dismiss.

The relevant statute, 42 U.S.C.